Hospital de Base | Integrated Research Center

São José do Rio Preto, São Paulo 15090-000

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, Atrial Fibrillation, EGFR Mutation, HER2 Mutation, Prevention of Stroke or Systemic Embolism

Studies at this site

• First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early